Previous studies have reported that ceramidase is up-regulated in AD (He et al., 2010), as well as the activity of sphingosine kinase 2 (Takasugi et al., 2011), which could be responsible for the significantly increased levels of S1P in APP/PS1 mice in the present study. The gene discussed is PSEN1; the disease is Alzheimer disease.